References
1. Yen-Pon, E.; Champagne, P. A.; Plougastel, L.; Gabillet, S.; Thuery,
P.; Johnson, M.; Muller, G.; Pieters, G.; Taran, F.; Houk, K. N.;
Audisio, D., Sydnone-Based Approach to Heterohelicenes through
1,3-Dipolar-Cycloadditions. J Am Chem Soc 2019,141 (4), 1435-1440.
2. Gracia-Vitoria, J.; Osante, I.; Cativiela, C.; Tejero, T.; Merino,
P., Experimental and Computational Studies on the 1,3-Dipolar
Cycloaddition between Enantiomerically Pure 2,3-Dihydrothiazoles and
Nitrones. Eur J Org Chem 2019, 2019 (27),
4426-4435.
3. Ren, D.; Hu, X.; Li, X., Synthesis of novel
dispiro[indoline-3,2’-pyrrolidine-3’,10”-thiazolo[3’,2’:1,2]pyrimido[5,4-g]indolizine]
derivatives by 1,3-dipolar cycloaddition reaction. Chemistry of
Heterocyclic Compounds 2019, 55 (3), 275-279.
4. Arhin, G.; Adams, A. H.; Opoku, E.; Tia, R.; Adei, E., 1, 3-Dipolar
cycloaddition reactions of selected 1,3-dipoles with
7-isopropylidenenorbornadiene and follow-up thermolytic cleavage: A
computational study. J Mol Graph Model 2019, 92 ,
267-279.
5. Yue, J.; Chen, S.; Zuo, X.; Liu, X.-L.; Xu, S.-W.; Zhou, Y.,
Diversity-oriented one-pot multicomponent synthesis of chromanone-based
3,3′-pyrrolidinyl-spirooxindoles via a 1,3-dipolar cycloaddition
reaction. Tetrahedron Letters 2019, 60 (2),
137-141.
6. Mortensen, K. T.; Osberger, T. J.; King, T. A.; Sore, H. F.; Spring,
D. R., Strategies for the Diversity-Oriented Synthesis of Macrocycles.Chem Rev 2019, 119 (17), 10288-10317.
7. Burke, M. D.; Schreiber, S. L., A planning strategy for
diversity-oriented synthesis. Angew Chem Int Ed Engl2004, 43 (1), 46-58.
8. Schreiber, S., Target-Oriented and Diversity-Oriented Organic
Synthesis in Drug Discovery. Science 2000, 287 (
5460), 1964-1969.
9. Arya, P.; Joseph, R.; Gan, Z.; Rakic, B., Exploring new chemical
space by stereocontrolled diversity-oriented synthesis. Chem Biol2005, 12 (2), 163-180.
10. Lu, T.; Wang, C.; Wang, G.; Wang, S.; Song, J.; Yin, H.; Fan, G.;
Chen, F.-X., 1,2,4-Oxadiazole-derived polynitro energetic compounds with
sensitivity reduced by a methylene bridge. New Journal of
Chemistry 2019, 43 (34), 13330-13333.
11. Chiacchio, M. A.; Legnani, L.; Campisi, A.; Paola, B.; Giuseppe, L.;
Iannazzo, D.; Veltri, L.; Giofre, S.; Romeo, R., 1,2,4-Oxadiazole-5-ones
as analogues of tamoxifen: synthesis and biological evaluation.Org Biomol Chem 2019, 17 (19), 4892-4905.
12. Srinivas, M.; Satyaveni, S.; Ram, B., Synthesis and Anticancer
Activity of 1,2,4-Oxadiazol Linked Benzimidazole Derivatives.Russian Journal of General Chemistry 2019, 88(12), 2653-2657.
13. Kumar, D.; Patel, G.; Vijayakrishnan, L.; Dastidar, S. G.; Ray, A.,
Design and synthesis of 3,5-disubstituted-1,2,4-oxadiazoles as potent
inhibitors of phosphodiesterase4b2. Chem Biol Drug Des2012, 79 (5), 810-818.
14. Cottrell, D. M.; Capers, J.; Salem, M. M.; DeLuca-Fradley, K.;
Croft, S. L.; Werbovetz, K. A., Antikinetoplastid activity of
3-aryl-5-thiocyanatomethyl-1,2,4-oxadiazoles. Bioorg Med Chem2004, 12 (11), 2815-2824.
15. Miralinaghi, P.; Salimi, M.; Amirhamzeh, A.; Norouzi, M.;
Kandelousi, H. M.; Shafiee, A.; Amini, M., Synthesis, molecular docking
study, and anticancer activity of triaryl-1,2,4-oxadiazole.Medicinal Chemistry Research 2013, 22 (9),
4253-4262.
16. Gakh, A. A.; Sosnov, A. V.; Krasavin, M.; Nguyen, T. L.; Hamel, E.,
Identification of diaryl 5-amino-1,2,4-oxadiazoles as tubulin
inhibitors: the special case of
3-(2-fluorophenyl)-5-(4-methoxyphenyl)amino-1,2,4-oxadiazole.Bioorg Med Chem Lett 2013, 23 (5), 1262-1268.
17. Muraglia, E.; Ontoria, J. M.; Branca, D.; Dessole, G.; Bresciani,
A.; Fonsi, M.; Giuliano, C.; Llauger Bufi, L.; Monteagudo, E.; Palumbi,
M. C.; Torrisi, C.; Rowley, M.; Steinkuhler, C.; Jones, P.,
N-(2-alkylaminoethyl)-4-(1,2,4-oxadiazol-5-yl)piperazine-1-carboxamides
as highly potent smoothened antagonists. Bioorg Med Chem Lett2011, 21 (18), 5283-5288.
18. Carette, X.; Blondiaux, N.; Willery, E.; Hoos, S.; Lecat-Guillet,
N.; Lens, Z.; Wohlkonig, A.; Wintjens, R.; Soror, S. H.; Frenois, F.;
Dirie, B.; Villeret, V.; England, P.; Lippens, G.; Deprez, B.; Locht,
C.; Willand, N.; Baulard, A. R., Structural activation of the
transcriptional repressor EthR from Mycobacterium tuberculosis by single
amino acid change mimicking natural and synthetic ligands. Nucleic
Acids Res 2012, 40 (7), 3018-3030.
19. Flipo, M.; Desroses, M.; Lecat-Guillet, N.; Villemagne, B.;
Blondiaux, N.; Leroux, F.; Piveteau, C.; Mathys, V.; Flament, M. P.;
Siepmann, J.; Villeret, V.; Wohlkonig, A.; Wintjens, R.; Soror, S. H.;
Christophe, T.; Jeon, H. K.; Locht, C.; Brodin, P.; Deprez, B.; Baulard,
A. R.; Willand, N., Ethionamide boosters. 2. Combining bioisosteric
replacement and structure-based drug design to solve pharmacokinetic
issues in a series of potent 1,2,4-oxadiazole EthR inhibitors. J
Med Chem 2012, 55 (1), 68-83.
20. Nakamura, A.; Kaneko, N.; Villemagne, V. L.; Kato, T.; Doecke, J.;
Dore, V.; Fowler, C.; Li, Q. X.; Martins, R.; Rowe, C.; Tomita, T.;
Matsuzaki, K.; Ishii, K.; Ishii, K.; Arahata, Y.; Iwamoto, S.; Ito, K.;
Tanaka, K.; Masters, C. L.; Yanagisawa, K., High performance plasma
amyloid-beta biomarkers for Alzheimer’s disease. Nature2018, 554 (7691), 249-254.
21. Senthil Periyasmay; Subbiah, S., Modifications to the process for
the synthesis of new 1,2,4-oxadiazole analogues and the short review on
synthetic methodologies of 1,2,4oxadiazoles. International Journal
of Life Sciences Research 2019, 7 (2), 87-104.
22. Jiang, C. S.; Fu, Y.; Zhang, L.; Gong, J. X.; Wang, Z. Z.; Xiao, W.;
Zhang, H. Y.; Guo, Y. W., Synthesis and biological evaluation of novel
marine-derived indole-based 1,2,4-oxadiazoles derivatives as
multifunctional neuroprotective agents. Bioorg Med Chem Lett2015, 25 (2), 216-220.
23. Kumpuga, B. T.; Itsuno, S., Synthesis of chiral polyesters of
cinchona alkaloid catalysts for enantioselective Michael addition of
anthrone to nitroalkenes. Journal of Catalysis 2018,361 , 398-406.
24. Nehal Ibrahim; Hany Ibrahim; Sothea Kim; Jean-Pierre Nallet; Nepveu,
F. o., Interactions between Antimalarial Indolone-N-oxide Derivatives
and Human Serum Albumin. Biomacromolecules 2010,11 (12), 3341-3351
25. Porter, J. D.; Vivas-Rodriguez, O. L.; Weaver, C. D.; Dickson, E.
J.; Alsafran, A.; DiMilo, E.; Arnold, L. A.; Dockendorff, C., An
anthrone-based Kv7.2/7.3 channel blocker with improved properties for
the investigation of psychiatric and neurodegenerative disorders.Bioorganic & Medicinal Chemistry Letters 2019,126681 .
26. Cheng, C.; Li, Z.; Shu, J.; Li, T.; Zhang, B., Synthesis of
isoxazolidines by 1,3-dipolar cycloaddition and their bioactivity.Frontiers of Chemistry in China 2006, 1 (4),
427-433.
27. Norman, M.; Minick, D.; Rigdon, G., Effect of linking bridge
modifications on the antipsychotic profile of some phthalimide and
isoindolillone derivatives. Journal Of Medicinal Chemistry1996, 39 (1), 149-157.
28. Pansare, S. V.; Lingampally; Rajinikanth; Kirby; Raie Lene,
Stereoselective Synthesis of 3-Aryloctahydroindoles and Application in a
Formal Synthesis of (-)-Pancracine. Organic Letters2010, 12 (3), 556-559
29. Miles, C.; Trehy, M.; Yost, R., Degradation Of N-Methylcarbamate and
Carbamoyl Oxime Pesticides In Chlorinated Water. Bulletin Of
Environmental Contamination and Toxicology 1988, 41(6), 838-843.
30. Frisch, M.; Clemente, F., Gaussian 09, Revision A. 01, MJ Frisch, GW
Trucks, HB Schlegel, GE Scuseria, MA Robb, JR Cheeseman, G.Scalmani, V. Barone, B. Mennucci, GA Petersson, H. Nakatsuji, M.
Caricato, X. Li, HP Hratchian, AF Izmaylov, J. Bloino, G. Zhe .
31. Jiang, K. M.; Luesakul, U.; Zhao, S. Y.; An, K.; Muangsin, N.;
Neamati, N.; Jin, Y.; Lin, J., Tautomeric-Dependent Lactam Cycloaddition
with Nitrile Oxide: Facile Synthesis of
1,2,4-Oxadiazole[4,5-a]indolone Derivatives. ACS Omega2017, 2 (7), 3123-3134.
32. Fukui, K.; Yonezawa, T.; Nagata, C.; Shingu, H., Molecular Orbital
Theory of Orientation in Aromatic, Heteroaromatic, and Other Conjugated
Molecules. The Journal of Chemical Physics 1954,22 (8), 1433-1442.